期刊文献+

MR IDEAL-QUANT及ESWAN成像技术评估肝纤维化铁质沉积的初步研究 被引量:5

Preliminary study on using IDEAL-QUANT and ESWAN imaging technique for evaluating iron deposition in liver fibrosis
原文传递
导出
摘要 目的:研究MR IDEAL-QUANT及ESWAN成像技术在评估肝纤维化患者肝内铁质沉积中的应用价值。方法:选取44例血清铁指标异常的肝纤维化患者(血清铁异常组)与12例血清铁指标正常的肝纤维化患者(对照组),行MR IDEAL-QUANT、ESWAN扫描,测量R2*值,对其与血清学肝纤维化相关指标进行相关性研究。结果:血清铁异常组与对照组间的MR IDEAL-QUANT、ESWAN成像R2*值差异有统计学意义(P<0.05)。血清铁异常组患者的R2*值(IDEAL-QUANT、ESWAN)与其血清铁蛋白水平间有中度正相关性(r=0.644、0.634、0.727、0.682,P<0.05),其中部分R2*值则与其血清转铁蛋白水平间有轻度负相关性(r=-0.310、-0.400、-0.417,P<0.05),余血清学指标与R2*值间无统计学相关性。结论:MR IDEAL-QUANT及ESWAN成像技术可用于观察肝纤维化患者肝内的铁质分布,并能定量评估肝内铁质沉积程度。 Objective: To study the value of IDEAL-QUANT and ESWAN imaging technique for evaluating iron deposition in liver fibrosis. Methods: MR IDEAL-QUANT and ESWAN scanning were performed in 44 liver fibrosis patients with abnormal serum iron indices (serum iron abnormal group) and 12 liver fibrosis patients with normal serum iron indices (control group). R2* value was measured and its correlation with liver fibrosis related serum indices was analyzed. Results: Statistically significant differences in R2* values (IDEAL-QUANT, ESWAN) were found between serum iron abnormal group and control group (P〈0.05). In serum iron abnormal group, moderate positive correlation was found between R2* values and ferritin(0.644,0.634, 0.727, 0.682), while mild negative correlation was seen between partial R2* values and transferrin (-0.310, -0.400, -0.417). Other serum indices had no correlation with R2* value (P〉0.05). Conclusions: MR IDEAL-QUANT and ESWAN imaging could be used for monitoring and evaluating the degree of iron deposition in liver fibrosis.
出处 《诊断学理论与实践》 2014年第2期146-151,共6页 Journal of Diagnostics Concepts & Practice
基金 上海市卫生局课题(2010040) 上海市中医药事业发展三年行动计划重大研究项目(ZYSNXD-CC-ZDYJ022) 国家自然科学基金项目(81071 154) 上海市科委重点项目(10411952200) 上海市高校一流学科(B类)建设项目
关键词 磁共振 成像技术 铁沉积 肝纤维化 Magnetic resonance Imaging technique Iron deposition Liver fibrosis
  • 相关文献

参考文献19

  • 1Mani H,Kieiner DE.Liver biopsy findings in chronic hepatitis B[J].Hepatology,2009,49(5 Suppl):S61-S71.
  • 2Franchini M,Targher G,Capra F,et aL The effect of iron depletion on chronic hepatitis C virus infection[J].Hepatol Int,2008,2(3):335-340.
  • 3Kohgo Y,Ohtake T,Ikuta K,et al.Iron accumulation in alcoholic liver diseases[J].Alcohol Clin Exp Res,2005,29(11 Suppl):189S-193S.
  • 4Sumida Y,Yoshikawa T,Okanoue T.Role of hepatic iron in non-alcoholic steatohepatitis[J].Hepatol Res,2009,39(3):213-222.
  • 5Lecube A,Hernandez C,Simo R.Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection:the role of iron overload[J].Diabetes Metab Res Rev,2009,25(5):403-410.
  • 6Soubasis N,Rallis TS,Vlemmas J,et al.Serum and liver iron concentration in dogs with experimentally induced hepatopathy[J].J Gastroenterol Hepatol,2006,21(3):599-604.
  • 7Souza RM,Freitas LA,Lyra AC,et al.Effect of iron overload on the severity of liver histologie alterations and on the response to interferon and ribavirin therapy of patients with hepatitis C infection[J].Braz J Med Biol Res,2006,39(1):79-83.
  • 8Nahon P,Ganne-Carri6 N,Trinchet JC,et al.Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis[J].Gastroenterol Clin Biol,2010,34(1):1-7.
  • 9Lin TJ,Liao LY,Lin CL,et al.Hepatic iron influences re-sponses to combination therapy with peginterferon alfa and ribavirin in chronic hepatitis C[J].Hepatogastroenterology,2008,55(85):1412-1415.
  • 10Fiorelli G,De Feo TM,Duca L,et al.Red blood cell antioxidant and iron status in alcoholic and nonalcoholic cirrhosis[J].Eur J Clin Invest,2002,32(Suppl 1):21-27.

二级参考文献8

共引文献30

同被引文献54

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部